Clinical trial
Gemcitabine in Treating Children With Refractory Solid Tumors
NCT00005577 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00005577 |
|---|---|
| Title | Gemcitabine in Treating Children With Refractory Solid Tumors |
| Official title | A PEDIATRIC PHASE I STUDY OF GEMCITABINE (NSC# 613327) IN SOLID TUMORS |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Childhood Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | gemcitabine hydrochloride |
| Enrollment | 30 |
| Start date | Aug 1, 1996 |
| Primary completion | Sep 1, 2002 |
| First posted | Apr 2, 2004 |
| Last update posted | Feb 5, 2013 |
| Countries | Australia, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: